Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tullis Health Investors, formerly known as Tullis-Dickerson, is a healthcare-focused venture capital and private equity firm founded in 1986. The firm specializes in growth-stage investments across medical devices, healthcare services, pharmaceuticals, and biotechnology. It manages several funds, including the Tullis-Dickerson Capital Focus III fund, to support companies from seed through late-stage development. Tullis provides both capital and strategic guidance, often taking active board roles to help portfolio companies achieve commercial success and liquidity. The firm's portfolio includes notable companies such as Exagen, electroCore, and TriSalus Life Sciences.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tullis-Dickerson Capital Focus III.